Vivani Medical, Inc. (VANI) - Dilution Analysis

10-Q filing | 81.3M shares outstanding

10-K filing | 84.6M shares outstanding

8-K filing: Vivani Medical, Inc. entered into a share purchase agreement for a private placement of 1,351,351 shares of common stock with an entity affiliated with Gregg Williams and a placement agency agreement with ThinkEquity LLC for a registered direct offering of 1,689,200 shares of common stock. ($4.5M proceeds)

10-Q filing | 73.0M shares outstanding

10-Q filing | 59.2M shares outstanding

8-K filing: Vivani Medical, Inc. entered into a Share Purchase Agreement for the purchase of 7,936,507 shares of common stock at $1.26 per share, resulting in expected gross proceeds of approximately $10.0 million. ($10.0M proceeds)

8-K filing: Vivani Medical, Inc. entered into a Share Purchase Agreement with Gregg Williams for the purchase of 2,912,621 shares of common stock at $1.03 per share, resulting in gross proceeds of approximately $3.0 million. ($3.0M proceeds)

10-Q filing | 59.2M shares outstanding

10-K filing | 59.2M shares outstanding

8-K filing: Vivani Medical, Inc. entered into a Share Purchase Agreement to sell 7,366,071 shares of common stock at $1.12 per share to an entity beneficially owned by Gregg Williams, resulting in gross proceeds of approximately $8.25 million. ($8.25M proceeds)

10-Q filing | 55.2M shares outstanding

10-Q filing | 55.0M shares outstanding

10-Q filing | 52.2M shares outstanding

S-3/A filing: This is an S-3/A filing to register additional securities, indicating the registrant is a non-accelerated filer and a smaller reporting company.

S-3 filing: The company is filing an S-3 to offer and sell up to $300,000,000 in aggregate principal amount of common stock, preferred stock, debt securities, warrants or units from time to time.

10-K filing | 0.1M shares outstanding

10-Q filing | 51.0M shares outstanding

10-Q filing | 50.8M shares outstanding

10-Q filing | 50.8M shares outstanding

10-K filing | 50.7M shares outstanding

10-Q filing | 50.7M shares outstanding

10-Q filing | 39.4M shares outstanding

8-K filing: Stock split 1-for-3 | Outstanding: 39,409,176 → 13,136,391

10-Q filing | 39.4M shares outstanding

10-K filing | 39.4M shares outstanding

8-K filing: Second Sight Medical Products, Inc. entered into a merger agreement with Nano Precision Medical, Inc. where Second Sight will issue approximately 134,349,464 shares of its common stock to Nano Precision Medical, Inc.'s security holders, representing approximately 77.32% of the total issued and outstanding shares of common stock of the Company on a fully converted basis.

10-Q filing | 39.4M shares outstanding

10-Q filing | 39.4M shares outstanding

8-K filing: Second Sight Medical Products announced the closing of an offering where it sold 11,500,000 shares of its common stock at a price of $5.00 per share for aggregate gross proceeds of $57.5 million. ($57.5M proceeds)

8-K filing: Second Sight Medical Products, Inc. announced the pricing of its underwritten public offering of 10,000,000 shares of its common stock at a public offering price of $5.00 per share, expecting to close on June 25, 2021. ($50.0M proceeds)

S-3 filing: The filing is for a shelf offering of common stock, preferred stock, debt securities, warrants, and units up to an aggregate amount of $250,000,000.

10-Q filing | 27.9M shares outstanding

S-3 filing: This S-3 filing registers 4,650,000 shares of common stock for resale by selling shareholders, with a proposed maximum aggregate offering price of $38,060,250 based on a price of $8.185 per share.

10-K filing | 23.3M shares outstanding

8-K filing: Second Sight Medical Products, Inc. entered into a Memorandum of Understanding with Pixium Vision, where Pixium will contribute certain assets in exchange for 34,876,043 newly issued common stock of Second Sight, representing approximately 60% of the share capital and voting rights of Second Sight, subject to the completion of a Fund Raising by Second Sight.

10-Q filing | 23.1M shares outstanding

10-Q filing | 23.1M shares outstanding

10-Q filing | 23.1M shares outstanding

10-K filing | 15.7M shares outstanding